Ceric Ammonium Nitrate (CAN) Promoted Efficient Synthesis of 1,5-Benzodiazepine Derivatives

Ravi Varala; Ramu Enugala; Sreelatha Nuvula; Srinivas R. Adapa

doi:10.1055/s-2006-939066

LETTER

Ceric Ammonium Nitrate (CAN) Promoted Efficient Synthesis of 1,5-Benzodiazepine Derivatives [1]

Ravi Varala, Ramu Enugala, Sreelatha Nuvula, Srinivas R. Adapa*
Indian Institute of Chemical Technology, Hyderabad - 500 007, India
Fax: +91(40)27160921; e-Mail: rvarala_iict@yahoo.co.in;

Abstract

All articles of this category

Abstract

Ceric ammonium nitrate was found to be an efficient reagent for the preparation of 1,5-benzodiazepine derivatives of a wide range of substituted o-phenylenediamines and electronically divergent ketones in moderate to excellent isolated yields (60-98%) under mild conditions using methanol as solvent at ambient temperature.

Key words

1,5-benzodiazepines - ceric ammonium nitrate - o-phenylenediamines

Full Text

References

References and Notes

1

IICT communication no: 050809.

2a Werner W. Baumgart J. Burckhardt G. Fleck WF. Geller K. Gutsche W. Hanschmann H. Messerschmidt A. Roemer W. Biophys. Chem. 1990, 35: 271

2b Herpin TF. Van Kirk KG. Salvino JM. Yu ST. Labaudinière RF. J. Comb. Chem. 2000, 5: 513

2c Claremon DA, Liverton N, Selnick HG, and Smith GR. inventors; PCT Int. Appl. WO 9640653.

3a Atwal KS. Bergey JL. Hedberg A. Moreland S. J. Med. Chem. 1987, 30: 635

3b Merluzzi V. Hargrave KD. Labadia M. Grozinger K. Skoog M. Wu JC. Shih C.-K. Eckner K. Hattox S. Adams J. Rosenthal AS. Faanes R. Eckner RJ. Koup RA. Sullivan JL. Science 1990, 250: 1411

3c Di Braccio M. Grossi G. Roma G. Vargiu L. Mura M. Marongiu ME. Eur. J. Med. Chem. 2001, 36: 935

3d Tranquillini ME. Cassara PG. Corsi M. Curotto G. Donati D. Finizia G. Pentassuglia G. Polinelli S. Tarzia G. Ursini A. Van Amsterdam FTM. Arch. Pharm. 1997, 330: 353

4a Schutz H. Benzodiazepines Springer; Heidelberg: 1982.

4b Landquist JK. In Comprehensive Heterocyclic Chemistry Vol. 1: Katritzky AR. Rees CW. Pergamon; Oxford: 1984. p.166-170

4c Randall LO. Kappel B. Benzodiazepines Garattini S. Mussini E. Randall LO. Raven Press; New York: 1973. p.27

5 Haris RC, and Straley JM. inventors; US Patent 1537757. ; Chem. Abstr. , 73, 100054w

6a Essaber M. Baouid A. Hasnaoui A. Benharref A. Lavergne J.-P. Synth. Commun. 1998, 28: 4097

6b El-Sayed AMEl. Abdel-Ghany H. El-Saghier AMM. Synth. Commun. 1999, 29: 3561

6c Xu JX. Wu HT. Jin S. Chin. J. Chem. 1999, 17: 84

6d Zhang XY. Xu JX. Jin S. Chin. J. Chem. 1999, 17: 404

6e Reddy KVV. Rao PS. Ashok D. Synth. Commun. 2000, 30: 1825

7a Herbert JAL. Suschitzky H. J. Chem. Soc., Perkin Trans. 1 1974, 2657

7b Morales HR. Ulbarela BA. Contreras R. Heterocycles 1986, 24: 135

7c Jung DI. Choi TW. Kim YY. Kim IS. Park YM. Lee YG. Jung DH. Synth. Commun. 1999, 29: 1941

7d Balakrishna MS. Kaboudin B. Tetrahedron Lett. 2001, 42: 1127

7e Curini M. Epifano F. Marcotullio MC. Rosati O. Tetrahedron Lett. 2001, 42: 3193

7f Kaboudin B. Navaee K. Heterocycles 2001, 55: 1443

7g Pozarentzi M. Stephanatou JS. Tsoleridis CA. Tetrahedron Lett. 2002, 43: 1755

7h Yadav JS. Reddy BVS. Eshwaraiah B. Anuradha K. Green Chem. 2002, 4: 592

7i Sabitha G. Reddy GSKK. Reddy KB. Reddy NM. Yadav JS. Adv. Synth. Catal. 2004, 346: 921

7j Yadav JS. Reddy BVS. Kumar SP. Nagaiah K. Synthesis 2005, 480

7k Jarikote DV. Siddiqui SA. Rajagopal R. Daniel T. Lahoti RJ. Srinivasan KV. Tetrahedron Lett. 2003, 44: 1835

7l De SK. Gibbs RA. Tetrahedron Lett. 2005, 46: 1811

8a Varala R. Ramu E. Alam MM. Adapa SR. Synlett 2004, 1747

8b Varala R. Ramu E. Alam MM. Adapa SR. Chem. Lett. 2004, 33: 1614

8c Varala R. Ramu E. Adapa SR. Bull. Chem. Soc. Jpn. 2006, 79: 140

8d Varala R. Alam MM. Adapa SR. Synlett 2003, 720

8e Alam MM. Varala R. Adapa SR. Tetrahedron Lett. 2003, 5115

8f Varala R. Alam MM. Adapa SR. Synlett 2003, 67

8g Varala R. Ramu E. Adapa SR. Tetrahedron Lett. 2006, 47: 877

8h Alam MM. Varala R. Ramu E. Adapa SR. Lett. Org. Chem. 2006, 3: 187

For recent reports, see:

9a Nair V. Balagopal L. Rajan R. Mathew J. Acc. Chem. Res. 2004, 37: 21

9b Kuttan A. Nowshudin S. Rao MNA. Tetrahedron Lett. 2004, 45: 2663

9c Comin MJ. Elhalem E. Rodriguez JB. Tetrahedron 2004, 60: 11851

9d Nair V. Suja TD. Mohanan K. Tetrahedron Lett. 2005, 46: 3217

9e Fujioka H. Ohba Y. Hirose H. Murai K. Kita Y. Org. Lett. 2005, 7: 3303

10

Representative Procedure.
A mixture of o-phenylenediamine (1.0 mmol), ketone (2.2 mmol) and CAN (0.055 g, 10 mol%) in MeOH (2 mL) was stirred at r.t. for the time specified in Table [1] . After the reaction was over, the reaction mixture was diluted with H₂O and extracted with Et₂O (3 ¥ 10 mL). The combined organic layers were dried over Na₂SO₄, concentrated in vacuo and purified by column chromatography on silica gel with EtOAc and n-hexane (2:8) as eluent to afford the corresponding pure 1,5-benzodiazapine. Previously reported materials were characterized by comparison of their NMR and mass spectra with those of authentic samples. All novel compounds gave satisfactory spectroscopic data in accordance to their proposed structures.
Spectral Data for Selected Compounds:
Compound 2: pale yellow crystalline solid, mp 98-99 °C. IR (KBr): 3318, 1630, 1598 cm^-1. ¹H NMR (200 MHz, CDCl₃): δ = 1.72 (s, 3 H), 2.26 (s, 3 H), 2.32 (s, 3 H), 2.98 (d, J = 13.38 Hz, 1 H), 3.05 (d, J = 13.38 Hz, 1 H), 3.43 (br s, NH), 6.76 (m, 1 H), 7.01 (m, 6 H), 7.23 (m, 1 H), 7.49 (m, 4 H). ¹³C NMR (75 MHz, CDCl₃): δ = 20.75, 21.16, 29.85, 42.97, 73.06, 121.28, 121.38, 125.18, 126.03, 127.15, 128.50, 128.67, 128.92, 129.22, 136.45, 137.0, 138.18, 139.76, 140.32, 144.98, 166.82. MS (EI): m/z = 340 [M⁺]. [7i]
Compound 3: yellowish solid, mp 114-116 °C. IR (neat): 3325, 1135, 1640, 1594 cm^-1. ¹H NMR (200 MHz, CDCl₃): δ = 1.71 (s, 3 H), 2.85 (d, J = 12.84 Hz, 1 H), 2.98 (d, J = 13.60 Hz, 1 H), 3.73 (s, 3 H), 3.77 (s, 3 H), 6.65-6.78 (m, 4 H), 6.95-7.02 (m, 2 H), 7.18-7.25 (m, 2 H), 7.42-7.55 (m, 4 H). MS (EI): m/z = 372 [M⁺].
Compound 4: yellow crystalline solid, mp 219-220 °C. IR (KBr): 3339, 1636, 1599 cm^-1. ¹H NMR (200 MHz, CDCl₃): δ = 1.65 (s, 3 H), 2.77 (d, J = 12.63 Hz, 1 H), 2.89 (d, J = 7.43 Hz, 1 H), 4.18 (br s, NH), 6.57-6.64 (m, 4 H), 6.81-7.00 (m, 1 H), 7.10-7.18 (m, 1 H), 7.28-7.55 (m, 4 H).
MS (EI): m/z = 344 [M⁺].
Compound 5: red crystalline solid, mp 156-158 °C. IR (KBr): 3325, 1642, 1597 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 1.83 (s, 3 H), 2.96 (d, J = 13.38 Hz, 1 H ), 3.27 (d, J = 13.38 Hz, 1 H), 3.52 (br s, NH), 6.98 (m, 1 H), 7.00 (m, 6 H), 7.22 (m, 1 H), 7.47 (m, 4 H). ¹³C NMR (75 MHz, CDCl₃): δ = 30.02, 42.92, 73.37, 121.29, 122.16, 123.53, 123.38, 126.78, 127.57, 127.75, 129.58, 137.23, 138.80, 144.65, 146.95, 148.40, 154.05, 163.82. MS (EI): m/z =
402 [M⁺].
Compound 6 (X = F): pale-yellow crystalline solid, mp 104-105 °C. IR (KBr): 3271, 1651, 1603, 1231 cm^-1.
¹H NMR (300 MHz, CDCl₃): δ = 1.75 (s, 3 H), 2.87 (d, J = 13.60 Hz, 1 H), 3.04 (d, J = 12.84 Hz, 1 H), 3.30 (br s, NH), 6.75-6.79 (m, 1 H), 6.82-6.92 (m, 4 H), 7.00-7.05 (m, 2 H), 7.19-7.25 (m, 1 H), 7.48-7.62 (m, 4 H). ¹³C NMR (75 MHz, CDCl₃): δ = 29.72, 42.94, 73.38, 114.70, 114.79, 114.97, 115.06, 126.22, 127.0, 128.50, 129.20, 135.46, 137.44, 140.36, 143.2, 160.23, 162.22, 165.26, 165.53, 163.50. MS (EI): m/z = 348 [M⁺].
Compound 9: pale-yellow crystalline solid; mp 102-103 °C. IR (KBr): 3325, 1636, 1594 cm^-1. ¹H NMR (200 MHz, CDCl₃): δ = 1.72 (s, 3 H), 2.26-2.36 (s, 6 H), 2.45 (s, 3 H), 2.58 (s, 3 H), 2.91 (d, J = 12.84 Hz, 1 H), 3.03 (d, J = 13.60 Hz, 1 H), 3.29 (br s, NH), 6.56 (s, 1 H), 7.02-7.07 (m, 1 H), 7.24-7.28 (m, 4 H), 7.47-7.53 (m, 2 H), 7.83-7.87 (d, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 19.12, 21.10, 29.88, 43.06, 72.88, 122.34, 125.24, 127.05, 128.44, 128.76, 128.94, 129.58, 129.60, 134.58, 136.56, 137.26, 137.96, 139.68, 166.76. MS (EI): m/z = 368 [M⁺].
Compound 10: yellow crystalline solid, mp 158-160 °C. IR (KBr): 3304, 1638, 1603, 761 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 1.75 (s, 3 H), 2.93 (d, J = 13.60 Hz, 1 H), 3.12 (d, J = 12.84 Hz, 1 H), 3.49 (br s, NH), 6.88 (s, 1 H), 7.13-7.30 (m, 5 H), 7.36 (s, 1 H), 7.50-7.53 (m, 5 H). ¹³C NMR (75 MHz, CDCl₃): δ = 29.97, 43.23, 72.97, 121.90, 124.14, 125.33, 127.30, 128.35, 128.76, 130.13, 137.84, 139.26, 146.83, 168.81. MS (EI): m/z = 381 [M⁺].
Compound 11: pale-yellow solid, mp 179-180 °C. IR (KBr): 3434, 1636, 1597, 817 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 1.75 (s, 3 H), 2.34 (s, 3 H), 2.37 (s, 3 H), 2.95 (d, J = 13.60 Hz, 1 H), 3.09 (d, J = 13.60 Hz, 1 H), 3.50 (br s, NH), 6.88 (s, 1 H), 7.05-7.09 (t, 3 H), 7.28 (s, 1 H), 7.38-7.44 (t, 3 H), 7.50-7.53 (d, 2 H). MS (EI): m/z = 409 [M⁺].
Compound 12: pale-yellow crystalline solid, mp 199-200 °C. IR (KBr): 3325, 1630, 1594 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 1.77 (s, 3 H), 2.88 (d, J = 13.60 Hz, 1 H), 3.11 (d, J = 13.60 Hz, 1 H), 3.48 (br s, NH), 6.92 (s, 1 H), 7.21-7.25 (m, 4 H), 7.38 (s, 1 H), 7.45-7.51 (m, 4 H). MS (FAB): m/z = 451 [M⁺ + 1].
Compound 13: reddish crystalline solid, mp 218-220 °C. IR (KBr): 3387, 1640, 1585 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 1.74 (s, 3 H), 2.69 (d, J = 9.82 Hz, 1 H), 2.82 (d, J = 11.33 Hz, 1 H), 2.93 (br s, NH), 6.92 (s, 1 H), 7.21-7.25 (m, 4 H), 7.38 (s, 1 H), 7.45-7.51 (m, 4 H). MS (FAB): m/z = 472 [M⁺ + 1].
Compound 15 (R = R¹ = Cl): reddish crystalline solid, mp 92-94 °C. IR (KBr): 3325, 1636, 1590 cm^-1. ¹H NMR (200 MHz, CDCl₃): δ = 1.35 (s, 6 H), 2.26 (s, 2 H), 2.34 (s, 1 H), 6.78 (s, 1 H), 7.18 (s, 1 H). MS (EI): m/z = 257 [M⁺].